- BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
IDrugs : the investigational drugs journal (2004-01-20)
R Todd Reilly
PMID14730469
ABSTRACT
BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.
MATERIALS
Product Number
Brand
Product Description
Mesna impurity D, European Pharmacopoeia (EP) Reference Standard
Pricing and availability is not currently available.
